Chevron’s Q1 2025 Performance: A Mixed Bag with a Miss on Revenue
Chevron's Q1 2025 results reveal a decrease in earnings compared to the previous year, yet they exceed the anticipated earnings per share.
BTC$62,407.00-2.47%
ETH$1,688.17-2.99%
USDT$0.9992+0.01%
USDC$0.9998+0.00%
XRP$1.12-3.85%
SOL$68.14-4.18%
TRX$0.3214+0.14%
FIGR_HELOC$1.01-0.76%
HYPE$66.72-6.86%
DOGE$0.0822-2.97%
USDS$0.9997-0.01%
RAIN$0.0144-0.80%
LEO$9.54-0.99%
ZEC$448.14-4.61%
XLM$0.2177-8.42%
BTC$62,407.00-2.47%
ETH$1,688.17-2.99%
USDT$0.9992+0.01%
USDC$0.9998+0.00%
XRP$1.12-3.85%
SOL$68.14-4.18%
TRX$0.3214+0.14%
FIGR_HELOC$1.01-0.76%
HYPE$66.72-6.86%
DOGE$0.0822-2.97%
USDS$0.9997-0.01%
RAIN$0.0144-0.80%
LEO$9.54-0.99%
ZEC$448.14-4.61%
XLM$0.2177-8.42%
Eaton Corporation's first quarter of 2025 results surpassed expectations with record earnings and sales.
Chevron's Q1 2025 results reveal a decrease in earnings compared to the previous year, yet they exceed the anticipated earnings per share.
The Cigna Group outperformed its expected earnings per share and revenue in the first quarter of 2025.
Meta and Microsoft have posted strong quarterly earnings, driven by advancements in AI and advertising revenue.
KKR's first quarter results reflect strong operational capabilities through a challenging quarter.
CVS Health Corporation reported strong financial results for the first quarter of 2025, with revenues and earnings surpassing expectations.
Air Products reported a challenging Q2 FY25 with adjusted EPS falling short of expectations.
Super Micro's stock faced a steep decline after disappointing financial results.
ADP's third-quarter fiscal 2025 results reveal a robust performance with revenue and earnings surpassing expectations.
Caterpillar Inc. faced a challenging first quarter in 2025, with sales and revenues dropping significantly compared to the previous year.
Humana Inc. reports a strong first quarter of 2025 with adj. EPS exceeding expectations,
American Tower Corporation's Q1 2025 results revealed a modest revenue increase but a steep decline in net income,
Pfizer's Q1 2025 results indicate a sound earnings performance, with adjusted EPS surpassing expectations.